Allen Nissenson - May 19, 2025 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director
Signature
/s/ Allen Nissenson
Stock symbol
ELTX
Transactions as of
May 19, 2025
Transactions value $
$0
Form type
4
Date filed
5/20/2025, 04:07 PM
Previous filing
Nov 25, 2024
Next filing
May 21, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nissenson Allen Director C/O ELICIO THERAPEUTICS, INC., 451 D STREET, 5TH FLOOR, SUITE 501, BOSTON /s/ Allen Nissenson 2025-05-20 0001441889

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (Right to Buy) Award $0 +7.9K $0.00 7.9K May 19, 2025 Common Stock 7.9K $5.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.